Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDIN-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE FOR THE TREATMENT OF MIGRAINE VIA THE ORAL OR INTRAVENOUS ROUTE
No-Receipt date
2022-04464 - 22/12/2022
No-Filing date
20220800053 - 22/12/2022
No-Granting date
8000957 - 05/10/2023
No-EPO application date
-
No-EPO granting date
-
Gazette No-Publication date of application
4/2023 - 10/05/2023
Gazette No-Publication date of granted patent
10/2023 - 13/11/2023
Expiration date
03/04/2035
Kind of title
Supplementary Protection Certificate for Medicinal Products
Legal status
VALID
Priorities
-
Active Substance of Supplementary Certificates
ΛΑΣΜΙΔΙΤΑΝΗ
IPC Classification
Related Documents
Related Titles
Type
Master title
Related title
[SPC]
20210401989
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1331960
COLUCID PHARMACEUTICALS, INC.
2530 MERIDIAN PARKWAY, SUITE 300
DURHAM, NC 27713
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
3416429
PILGRIM, ALISON
3416430
WHITE, JAMES, F.
3416431
RUPNIAK, NADIA, M., J.
Representatives
Code
Firstname
Surname
Address
Town
Zip
3463
MARIA
ATHANASIADOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
848
EFANGELIA
GIAZITZOGLOU - THOMAIDOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Title Instruments
Payments history
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).